Ankyra Therapeutics, Inc. — Form D
Ankyra Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-15. The offering totals $14.5M, of which $14.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-05-15
- Form: D
- Accession: 0001811511-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $14.5M
- Amount sold: $14.5M
- Investors: 4
- Date of first sale: 2020-05-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367078
Issuer
- Name: Ankyra Therapeutics, Inc.
- CIK: 0001811511
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 83 NEWBURY STREET, BOSTON, MA, 02116
- Phone: 617-823-2399
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ajay Royan | Director | Leawood, KS |
| Philip Ferneau | Director | Hanover, NH |
| Terrance McGuire | Director | Cambridge, MA |
| Tillman Gerngross | Director | Waltham, MA |
| Tillman Gerngross | Executive Officer | Waltham, MA |
Other filings by this issuer (1)
More